SYNGENE INTERNATIONAL LIMITED UNIT IV BLOCK S. 12

SYNGENE INTERNATIONAL LIMITED UNIT IV BLOCK S. 12

Factory

Company Introduction:

Syngene International Limited is a leading integrated research, development, and manufacturing organization (CRDMO) based in India. It provides comprehensive scientific services to clients in the pharmaceutical, biotechnology, nutrition, animal health, and consumer goods sectors globally. Syngene offers a wide range of services spanning early discovery, process development, clinical development, and commercial manufacturing.

The company operates state-of-the-art research laboratories and manufacturing facilities. Its services include discovery chemistry, discovery biology, safety assessment, development services (formulation and analytical development), and manufacturing services (clinical and commercial scale manufacturing of small molecules, biologics, and other advanced intermediates).

Unit IV Block S. 12 refers to one of Syngene's operational sites, which houses various laboratories and manufacturing capabilities crucial for its CRDMO activities. These units are equipped to handle complex scientific projects, from initial research to the large-scale production of active pharmaceutical ingredients (APIs) and other specialized products. Therefore, this unit functions as a manufacturing facility and a research and development center.

SYNGENE INTERNATIONAL LIMITED UNIT IV BLOCK S. 12, India, operates as a Contract Research, Development, and Manufacturing Organization (CRDMO). They do not produce or sell finished pharmaceutical products directly to consumers or the general market under their own brand. Instead, they provide a comprehensive suite of scientific services to global pharmaceutical, biotechnology, nutrition, animal health, and consumer goods companies. These services are what they "produce" and "sell" in their business model.

Their primary offerings include:

1. Discovery Services: This includes target identification and validation, hit identification (such as high-throughput screening and fragment-based drug discovery), lead generation and optimization, medicinal chemistry, computational chemistry, and structural biology.

2. Development Services: These encompass preclinical development (including safety assessment, toxicology studies, pharmacokinetics, and ADME studies), analytical development, process development, and formulation development.

3. Manufacturing Services: They provide manufacturing of Active Pharmaceutical Ingredients (APIs) and drug products specifically for clinical trials. This also extends to biologics manufacturing, covering cell line development, process development, analytical development, and clinical manufacturing of biologics.

4. Biologics Services: Specialized services for biological drugs, including cell line development, biologics process development, biologics analytical development, and biologics clinical manufacturing.

5. In Vitro and In Vivo Biology Services: This involves various biological studies such as pharmacology, cell biology, and molecular biology research.